Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Nurix Therapeutics (NRIX) Receivables - Net (2021 - 2025)

Nurix Therapeutics (NRIX) has disclosed Receivables - Net for 4 consecutive years, with $19.0 million as the latest value for Q2 2025.

  • Quarterly Receivables - Net changed N/A to $19.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $19.0 million through May 2025, changed N/A year-over-year, with the annual reading at $6.0 million for FY2021, N/A changed from the prior year.
  • Receivables - Net for Q2 2025 was $19.0 million at Nurix Therapeutics, up from $2.0 million in the prior quarter.
  • The five-year high for Receivables - Net was $19.0 million in Q2 2025, with the low at $2.0 million in Q3 2023.
  • Average Receivables - Net over 4 years is $7.1 million, with a median of $6.0 million recorded in 2021.